SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
response after non
on 10 Dec 2024
Last Applicant/ Owned by
5928 Pascal Ct., Suite 100/150
Carlsbad
CA
92008
Serial Number
90364536 filed on 07th Dec 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
BIOLOGY TO BARCODES
Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood component separation apparatus for medical purposes; Blood containers for medical purposes; Blood filters; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Filters for blood and blood components f Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
DNA screening for medical purposes; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnosis and treatment of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnosis of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnostic testing, monitoring and reporting services; Medical dosimetry services for treating radiation exposure; Medical screening; Medical screening services in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing of urine, blood, hair follicles and breath; Providing cancer screening services; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing information in the field of diabetes; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals
First Use Date in General
30th Mar 2021
First Use Date in Commerce
30th Mar 2021
Class [010]
Medical Instrument Products
Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood component separation apparatus for medical purposes; Blood containers for medical purposes; Blood filters; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Filters for blood and blood components for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus for detecting cancer; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing or treating respiratory conditions, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical device for detecting cancer; Medical devices for dosimetry purposes in the field of radiotherapy; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk with integrated recorded operating system software, sold as a unit; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk with integrated recorded software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways, sold as a unit; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing the presence of nucleic acids and antigens, and modifications thereof, gene expression, tissue structures, radiation exposure; Medical diagnostic apparatus for testing biological samples, DNA, RNA, proteins, viruses, single cells, tissue, organs, biochemical preparations, and waste water incorporating recorded operating system software; Medical diagnostic instruments for the analysis of body fluids; Medical instruments for analysing and identifying bacteria; Medical instruments for analyzing and identifying bacteria; Medical instruments for use in treating cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical instruments, namely, biosensors for detecting infectious diseases; Medical specimen collection devices in the nature of bottles, tubes, swabs, syringes, and wipes for the collection of nasal mucus, respiratory droplets, saliva, blood, urine, and feces; Sample preparation device for medical diagnostic uses
First Use Date in General
30th Mar 2021
First Use Date in Commerce
30th Mar 2021
Class [005]
Pharmaceutical Products
Chemical reagents for medical or veterinary purposes; Clinical medical reagents; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzymes for medical purposes; Enzymes for veterinary purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, water analysis, and liquid biopsy; Nucleic acid sequences and chemical reagents for medical and veterinary purposes
First Use Date in General
30th Mar 2021
First Use Date in Commerce
30th Mar 2021
Mark Details
Serial Number
No 90364536
Mark Type
No Service Mark
Attorney Docket Number
No T3376.L02.US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Dec 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 10th Dec 2024 | ASSIGNED TO LIE |
| 10th Dec 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 31st Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 31st Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 01st Aug 2024 | NON-FINAL ACTION E-MAILED |
| 01st Aug 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 01st Aug 2024 | SU - NON-FINAL ACTION - WRITTEN |
| 15th Feb 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 14th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |